Objective: This study aimed to assess the prevalence of hypogonadism and its risk factors in Brazilian men with Diabetes Mellitus type 2, as well as testing the accuracy of laboratory diagnosis against The Androgen Deficiency in Aging Males (ADAM) questionnaire for the initial screening of testosterone deficiency. Methodology: A cross-sectional study was conducted with 38 type 2 diabetic men between January and May 2023 at the primary care using plasma testosterone levels for hypogonadism detection and the ADAM questionnaire comparatively. Statistical analyses were performed for normality, correlation, and association. All participants signed a free and informed consent form approved by the Ethics Committee. Results: The research identified a prevalence of hypogonadism of 47.1% among the participants. Factors such as advanced age, BMI >30.0 kg/m2, increased abdominal circumference, and high total cholesterol were associated with hypogonadism in type 2 diabetics. The ADAM questionnaire had modest accuracy (41.2%) (despite the participants' reliable response pattern (Cronbach`s alpha = 0.72). Conclusion: Hypogonadism is common in type 2 diabetics and was prevalent in almost half of the participants being associated to cardiovascular risk factors. The ADAM questionnaire had a poor performance in detecting hypogonadism in this group.
Adami et al. (Fri,) studied this question.